G2E Co.
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $17M
Investors
- 9
About G2E Co.
, Ltd. operates as a healthcare platform company that manufactures and sells platform-based insulin auto-injectors to help treat diabetes., Ltd. The firm manufactures and sells platform-based insulin auto-injectors such as pumps and pens used in diabetes treatment and solutions. The firm also operates a patient care and diagnosis platform that enables users to examine patients remotely, utilize diagnostic equipment, and coordinate with doctors.
Who invested in G2E Co.
9 investors across 4 rounds
See all investors in G2E Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about G2E Co.
Who invested in G2E Co.?
G2E Co. has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has G2E Co. raised?
G2E Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did G2E Co. last raise money?
G2E Co.'s most recent round on record is a Series B, in Dec 2023.
What does G2E Co. do?
G2E Co. is a medical devices & equipment company.
Where is G2E Co. headquartered?
G2E Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like G2E Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at G2E Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like G2E Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.